The global Carbamazepine market starts to normalize after in early June a sharp downturn in May 2025, with India leading a strategic price correction driven by softened production costs and recalibrated downstream demand. A steady fall in toluene prices — essential in Carbamazepine’s production — over April and May eased manufacturing expenses, prompting suppliers to adjust prices. With cautious procurement by pharmaceutical manufacturers and reduced imports in the USA, Brazil, and Europe, the market faces short-term pressure but is expected to stabilize and gradually recover as inventories deplete and demand rebounds.
The market of global Carbamazepine has experienced signs of normalization in early June 2025 after a sharp downturn in May. India which is a dominant pharmaceutical export hub was leading the market price correction. The decline was a reflection of strategic price adjustment by API...
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
